06:20:17 EDT Sun 21 Apr 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:CLVS from 2018-04-20 to 2019-04-19 - 43 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-04-10 07:15CLVSNews ReleaseNew Research: Key Drivers of Growth for Weatherford International, J. C. Penney, SBA Communications, Clovis Oncology, Gladstone Land, and BCE — Factors of Influence, Major Initiatives and Sustained Production
2019-04-02 08:30CLVSNews ReleaseClovis Oncology Announces Interim Results from Rubraca ® (rucaparib) Phase 2 Study in Advanced Pancreatic Cancer and Nonclinical Data in Multiple Solid Tumor Types for Rucaparib and Lucitanib Presented at AACR 2019
2019-03-19 08:00CLVSNews ReleaseClovis Oncology Announces Presentations at 2019 AACR Annual Meeting
2019-03-16 12:45CLVSNews ReleaseClovis Oncology to Highlight Rubraca ® (rucaparib) Data from Post-Hoc ARIEL3 Analyses at SGO 2019 Congress
2019-03-06 16:19CLVSNews ReleaseClovis Oncology to Present at the Barclays Global Healthcare Conference
2019-03-04 03:00CLVSNews ReleaseClovis Oncology Announces Availability of Rubraca ®? (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Germany
2019-02-26 08:00CLVSNews ReleaseClovis Oncology Announces 2018 Operating Results
2019-02-22 08:00CLVSNews ReleaseClovis Oncology to Present at the 8th Annual SVB Leerink Healthcare Conference
2019-02-19 07:00CLVSNews ReleaseAlkermes and Clovis Oncology Initiate Research Collaboration to Explore Combination Cancer Therapies
2019-02-13 07:30CLVSNews ReleaseNew Research Coverage Highlights Amicus Therapeutics, Clovis Oncology, YRC Worldwide, FORTERRA INC, Shenandoah Telecommunications, and Basic Energy Services — Consolidated Revenues, Company Growth, and Expectations for 2019
2019-02-12 08:00CLVSNews ReleaseClovis Oncology to Announce Fourth Quarter/Fiscal Year 2018 Financial Results and Host Webcast Conference Call on February 26
2019-01-24 12:28CLVSNews ReleaseClovis Oncology Announces European Commission Authorization of Rubraca ®? (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer
2019-01-07 08:00CLVSNews ReleaseClovis Oncology Announces Product Revenues for the Fourth Quarter and Full Year 2018
2019-01-02 16:05CLVSNews ReleaseClovis Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
2018-12-26 07:25CLVSNews ReleaseDetailed Research: Economic Perspectives on Canopy Growth, ArQule, MoneyGram International, Teradata, Clovis Oncology, and Axovant Sciences — What Drives Growth in Today's Competitive Landscape
2018-12-13 12:46CLVSNews ReleaseCHMP Grants Positive Opinion for New Indication of Clovis Oncology ’s Rubraca ®? (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer
2018-12-04 07:37CLVSNews ReleaseClovis Oncology Announces Positive Outcome in European Opposition Proceeding Related to Rubraca ®
2018-11-20 08:07CLVSNews ReleaseClovis Oncology Announces Second U.S. Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with Expiration in 2035
2018-11-12 07:40CLVSNews ReleaseRecent Analysis Shows Clovis Oncology, Evertec, Etsy, Ring Energy, Ocular Therapeutix, and Destination Maternity Market Influences — Renewed Outlook, Key Drivers of Growth
2018-11-07 08:00CLVSNews ReleaseClovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference
2018-10-30 16:05CLVSNews ReleaseClovis Oncology Announces Third Quarter 2018 Operating Results
2018-10-19 06:01CLVSNews ReleaseClovis Oncology Presents Initial Results from the Ongoing Rubraca ® (rucaparib) TRITON Program in Metastatic Castration Resistant Prostate Cancer (mCRPC) at ESMO 2018 Congress
2018-10-18 09:00CLVSNews ReleaseAnalysis: Positioning to Benefit within Clovis Oncology, Destination Maternity, MSG Networks, Lindblad Expeditions, NetScout, and ANI Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
2018-10-16 08:00CLVSNews ReleaseClovis Oncology to Announce Third Quarter 2018 Financial Results and Host Webcast Conference Call on October 30
2018-10-11 16:05CLVSNews ReleaseClovis Oncology Appoints Two New Directors to its Board
2018-10-03 06:00CLVSNews ReleaseClovis Oncology to Highlight Results from Rubraca ® (rucaparib) TRITON Prostate Program at ESMO 2018 Congress
2018-10-02 08:00CLVSNews ReleaseClovis Oncology Receives Breakthrough Therapy Designation for Rubraca ® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC)
2018-09-06 08:00CLVSNews ReleaseClovis Oncology to Present at the Morgan Stanley Global Healthcare Conference
2018-08-27 07:45CLVSNews ReleaseRecent Analysis Shows KalVista Pharmaceuticals, IZEA, Sonic Automotive, Catabasis Pharmaceuticals, ANI Pharmaceuticals, and Clovis Oncology Market Influences — Renewed Outlook, Key Drivers of Growth
2018-08-08 08:00CLVSNews ReleaseClovis Oncology Announces First Patient Enrolled in the Phase 3 ATHENA Trial
2018-08-01 16:05CLVSNews ReleaseClovis Oncology Announces Second Quarter 2018 Operating Results
2018-07-18 08:00CLVSNews ReleaseClovis Oncology to Announce Second Quarter 2018 Financial Results and Host Webcast Conference Call on August 1
2018-07-05 08:00CLVSNews ReleaseClovis Oncology Receives EMA Validation for its Application for a New Indication for Rubraca ®? (rucaparib) as Maintenance Treatment for Women with Recurrent Ovarian Cancer
2018-06-26 07:50CLVSNews ReleaseAnalysis: Positioning to Benefit within PBF Energy, Callaway Golf, Total System Services, Comcast, The Cheesecake Factory, and Clovis Oncology — Research Highlights Growth, Revenue, and Consolidated Results
2018-06-11 16:05CLVSNews ReleaseClovis Oncology to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 2018
2018-06-04 06:00CLVSNews ReleaseClovis Oncology Submits Application to EMA to Expand Use of Rubraca ®? (rucaparib) to Include Maintenance Treatment for Women with Recurrent Ovarian Cancer
2018-06-03 20:00CLVSNews ReleaseClovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers
2018-05-29 08:00CLVSNews ReleaseClovis Oncology Announces European Commission Authorization of Rubraca ® (rucaparib) for Women with Recurrent Ovarian Cancer
2018-05-16 11:55CLVSNews ReleaseClovis Oncology Announces Presentations at 2018 ASCO Annual Meeting
2018-05-09 18:08CLVSNews ReleaseCORRECTING and REPLACING Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018
2018-05-09 07:35CLVSNews ReleaseConsolidated Research: 2018 Summary Expectations for Catalent, MGIC Investment, United Rentals, Clovis Oncology, Pure Storage, and Chipotle Mexican Grill — Fundamental Analysis, Key Performance Indications
2018-05-08 16:05CLVSNews ReleaseClovis Oncology Announces First Quarter 2018 Operating Results
2018-04-24 16:15CLVSNews ReleaseClovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8